Lipid Class Separation Using UPC 2 /MS

Similar documents
A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

Fast Separation of Triacylglycerols in Oils using UltraPerformance Convergence Chromatography (UPC 2 )

Rapid Lipid Profiling of Serum by Reverse Phase UPLC-Tandem Quadrupole MS

Analysis of the Non-Ionic Surfactant Triton-X Using UltraPerformance Convergence Chromatography (UPC 2 ) with MS and UV Detection

Profiling Flavonoid Isomers in Highly Complex Citrus Juice Samples Using UPLC Ion Mobility Time-of-Flight Mass Spectrometry

Method Development for the Analysis of Endogenous Steroids Using Convergence Chromatography with Mass Spectrometric Detection

Automated Lipid Identification Using UPLC/HDMS E in Combination with SimLipid

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

Impact of Chromatography on Lipid Profiling of Liver Tissue Extracts

Applying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis

Comparison of a UPLC Method across Multiple UHPLC Systems

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

The use of mass spectrometry in lipidomics. Outlines

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Probing for Packaging Migrants in a Pharmaceutical Impurities Assay Using UHPLC with UV and Mass Detection INTRODUCTION

Data Independent MALDI Imaging HDMS E for Visualization and Identification of Lipids Directly from a Single Tissue Section

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Andrea Perissi Specialista Applicativo, Waters Italia Waters Corporation 1

Removal of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)

Mass Spectrometry based metabolomics

A RAPID AND SENSITIVE UPLC/UV/MS METHOD FOR SIMVASTATIN AND LOVA S TAT IN IN SU P P O RT O F C L E A NING VA L I DAT IO N S T U DIES

[ APPLICATION NOTE ] The Separation of 8 -THC, 9 -THC, and Their Enantiomers by UPC 2 Using Trefoil Chiral Columns INTRODUCTION APPLICATION BENEFITS

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Phospholipid characterization by a TQ-MS data based identification scheme

[ APPLICATION NOTE ] Profiling Mono and Disaccharides in Milk and Infant Formula Using the ACQUITY Arc System and ACQUITY QDa Detector

New Frontiers for MS in Metabolipidomics

[ application note note ] ]

USP Method Transfer of Ziprasidone HCl from HPLC to UPLC

Rapid Quantitative Analysis of Cannabidiol from Consumer Products Using UltraPerformance Convergence Chromatography

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

The Application of UPLC/MS E for the Analysis of Bile Acids in Biological Fluids

Jose Castro-Perez, Henry Shion, Kate Yu, John Shockcor, Emma Marsden-Edwards, Jeff Goshawk Waters Corporation, Milford, MA, U.S. and Manchester, UK

John P. McCauley and Rui Chen Waters Corporation, Milford, MA, USA INTRODUCTION APPLICATION BENEFITS WATERS SOLUTIONS KEY WORDS

A High Sensitivity UPLC/MS/MS Method for the Analysis of Clopidogrel and Clopidogrel Carboxylic Acid Metabolite in Human K 2 EDTA Plasma

Increased Identification Coverage and Throughput for Complex Lipidomes

INTRODUCTION CH 3 CH CH 3 3. C 37 H 48 N 6 O 5 S 2, molecular weight Figure 1. The Xevo QTof MS System.

[application note] DIRECT TISSUE IMAGING AND CHARACTERIZATION OF PHOSPHOLIPIDS USING A MALDI SYNAPT HDMS SYSTEM

Supplementary Information

Analysis of Food Sugars in Various Matrices Using UPLC with Refractive Index (RI) Detection

Analysis of N-Linked Glycans from Coagulation Factor IX, Recombinant and Plasma Derived, Using HILIC UPLC/FLR/QTof MS

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

A UPLC/MS Approach for the Diagnosis of Inborn Errors of Metabolism

Rapid Analysis of Bisphenols A, B, and E in Baby Food and Infant Formula Using ACQUITY UPLC with the Xevo TQD

Essential Lipidomics Experiments using the LTQ Orbitrap Hybrid Mass Spectrometer

Metabolomic and Lipidomic Research in Diabetes and Obesity 08/07/2013

Simultaneous Analysis of Intact Human Insulin and Five Analogs in Human Plasma Using μelution SPE and a CORTECS UPLC Column

CHARACTERIZATION AND DETECTION OF OLIVE OIL ADULTERATIONS USING CHEMOMETRICS

Supporting Information

Agilent Solutions for Lipidomics. Greater Insight into

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

LC-Based Lipidomics Analysis on QTRAP Instruments

What You Can t See Can Hurt You. How MS/MS Specificity Can Bite Your Backside

Quantification of Budesonide Using UPLC and Xevo TQ-S

Ultra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification

Development of a High Sensitivity SPE-LC-MS/MS Assay for the Quantification of Glucagon in Human Plasma Using the ionkey/ms System

Quantitation of Sphingolipids in Tissue Extracts by LC/MS/MS

Glycerolipid Analysis. LC/MS/MS Analytical Services

[ APPLICATION NOTE ] Oasis PRiME HLB Cartridge for Cleanup of Infant Formula Extracts Prior to UPLC-MS/MS Multiresidue Veterinary Drugs Analysis

Supporting information

The Development of LC/MS Methods for Determination of Polar Drugs of Abuse in Biological Samples

John Haselden 1, Gordon Dear 1, Jennifer H. Granger 2, and Robert S. Plumb 2. 1GlaxoSmithKline, Ware, UK; 2 Waters Corporation, Milford, MA, USA

Comprehensive Two-Dimensional HPLC and Informative Data Processing for Pharmaceuticals and Lipids

Supporting information

A Metabolomics Approach to Profile Novel Chemical Markers for Identification and Authentification of Terminalia Species

The Raptor HILIC-Si Column

Meeting Challenging Requirements for the Quantitation of Regulated Growth Promoters Dexamethasone and Betamethasone in Liver and Milk

The Development of LC/MS Methods for Determination of MDMA (Ecstasy) and Metabolites in Biological Samples

PosterREPRINT RAPID, SELECTIVE SCREENING OF URINE SAMPLES FOR GLUCURONIDES BY LC/MS/MS INTRODUCTION ABSTRACT

Achieve Broad Lipid Quantitation using a High-Throughput Targeted Lipidomics Method

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Identification & Confirmation of Structurally Related Degradation Products of Simvastatin

Improved method for the quantification of lysophospholipids including enol ether

Reducing Sample Volume and Increasing Sensitivity for the Quantification of Human Insulin and 5 Analogs in Human Plasma Using ionkey/ms

Impact of Reversed-Phase Chiral Chromatography on the LC-MS Analysis of Drugs in Biological Fluids

Using Hydrophilic Interaction Chromatography (HILIC) for the Retention of Highly Polar Analytes

High-Resolution Analysis of Intact Triglycerides by Reversed Phase HPLC Using the Agilent 1290 Infinity LC UHPLC System

Providing a Universal, One-step Alternative to Liquid-Liquid Extraction in Bioanalysis

Enrichment of Phospholipids from Biological Matrices with Zirconium Oxide-Modified Silica Sorbents

SEPARATION OF BRANCHED PFOS ISOMERS BY UPLC WITH MS/MS DETECTION

Metabolomic fingerprinting of serum samples by direct infusion mass spectrometry

ACE C18-AR Use the Power!

High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines

SWATH Acquisition Enables the Ultra-Fast and Accurate Determination of Novel Synthetic Opioids

Neosolaniol. [Methods listed in the Feed Analysis Standards]

ACQUITY UPLC WITH PDA DETECTION: DETERMINING THE SENSITIVITY LIMITS OF OXYBUTYNIN AND RELATED COMPOUNDS

Core E Analysis of Neutral Lipids from Human Plasma June 4, 2010 Thomas J. Leiker and Robert M. Barkley

Automated Purification and Analytical Reinjection of a Small Molecule Drug, Probenecid, on a Gilson LC/MS Dual Function System

[Application Note] TOXICOLOGY SCREENING BY UPLC/PDA IN COMBINATION WITH AN EXTENSIVE COMPOUND LIBRARY

INTRODUCTION TO MALDI IMAGING

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

14 Separation of the Phosphatidylcholines Using Reverse Phase HPLC

Dry eye disease commonly known as atopic keratoconjunctivitis is an autoimmune disease of

Mass-Spectrometric Analysis of Lipids (Lipidomics)

Life Science and Chemical Analysis Solutions. Baljit Ubhi, Jeff Patrick, David Alonso, and Joe Shambaugh 1 2 3

Transcription:

Michael D. Jones, 1,3 Giorgis Isaac, 1 Giuseppe Astarita, 1 Andrew Aubin, 1 John Shockcor, 1 Vladimir Shulaev, 2 Cristina Legido-Quigley, 3 and Norman Smith 3 1 Waters Corporation, Milford, MA, USA 2 Department of Biological Sciences, Center for Plant Lipid Research, University of North Texas, Denton, Texas, USA 3 Pharmaceutical Science Division, School of Biomedical and Health Sciences, King s College, London, UK A P P L I C AT IN B E N E F I T S Provides ACQUITY UPC 2 methodology conditions for comprehensive lipid intra- and inter-class analysis Highlights the method parameters that aid as method development tools for comprehensive lipid profiling Provides a single separation technique and a single instrumentation approach for rapid lipids analyses WAT E R S S LU T INS ACQUITY UPC 2 System with MS detection Empower 3 Software ACQUITY UPC 2 columns INT R DU C T IN The analysis of complex lipids has historically been a challenging task and may require a variety of analytical techniques. Lipids are generally recognized as hydrophobic compounds, but the properties of complex lipids containing phosphorus, sulfur, sugar, and nitrogen have a wide polarity range. Developing separation-based methodology utilizing a single technique is recognized as a common challenge for scientists researching lipidomic and metabolomic applications. Recent advances in technology have revived the exploration of supercritical fluid chromatography (SFC) as a viable analytical technique. Research and development focused on improvements of SFC instrumentation has provided a holistically designed chromatographic system that utilizes liquid C 2 as a mobile phase to leverage the chromatographic principles and selectivity of normal phase chromatography while providing the ease-of-use of reversed phase LC (RPLC). This new separation technique is referred to as UltraPerformance Convergence Chromatography (UPC 2 ). In this application note, UPC 2 technology is implemented for the analysis of lipid class separation. Method variables influencing the peak integrity and chromatographic separation for a mixture of lipids with different degrees of polarity are explored. The experiments were designed to understand the chromatographic behavior of lipids in a controlled setting using a variety of lipid extracts. Acyl chain length and a number of double bond influences were investigated using single moiety standards. The methodology parameters were tested using lipid extracts composed of intra-class components. The method conditions are applied to biological lipid extracts, whereas method adjustments are investigated to manipulate the chromatography based on the goal of the analyst. Insights from these method variable manipulations help to scope the development of targeted lipid profiling and screening protocols. K E Y W R D S UPC 2, MS, UPC 2 /MS E, lipidomics, metabolomics, method development, convergence chromatography 1

E X P E R IM E N TA L Lipid abbreviations CER Ceramides SM Sphingomyelin PG Phosphatidylglycerol PE Phosphatidylethanolamine PC Phosphatidylcholine LPC Lyso-Phosphatidylcholine LPE Lyso-Phosphatidylethanolamine Sample Description Samples and standards were purchased from Avanti Polar Lipids. Mix 1 and Mix 2 were brain (porcine) extracts except LPC and PG which were egg (chicken) extracts. Stocks were prepared in 5:5 chloroform/methanol. Working lipid mixtures were prepared to the specified concentration. Mix 1: Ceramide, SM, (5 mg/ml) PG, PE, PC, (.1 mg/ml) Mix 2: LPC, LPE, (5 mg/ml) Mix 3: 1:1 of [mix 1] and [mix 2] UPC 2 conditions System: ACQUITY UPC 2 Columns: ACQUITY UPC 2 BEH and HSS C 1 SB Column temp.: 6 C Sample temp.: 1 C Injection volume: 1 µl Flow rate: 1.5 ml/min Back pressure: 15 psi Mobile phase A: C 2 Mobile phase B: 5:5 methanol/acetonitrile with 1 g/l ammonium formate Gradient: Refer to figures for detailed information MS conditions Mass spectrometers: ACQUITY SQD and SYNAPT G2 MS Ionization mode: ESI positive Acquisition range : Capillary voltage : Cone voltage : Informatics: 1 to 15 Da 3.5 kv 3 V Empower 3 and MassLynx Software 2

R E SU LT S A N D D IS C U S S IN MS ptimization The ACQUITY UPC 2 System was configured with an ACQUITY single quadrupole detector (SQD) for this preliminary investigation of chromatographic parameters. Injections of [Mix 3] were screened with different cone and capillary voltages to determine the best operating conditions. Based on the cone voltage screening results, 3 V was chosen for controlling overall in-source fragmentation of the optimal signal for the spectra of L-α-phosphatidylglycerol (egg PG) to provide precursor ion and valuable fragmentation information, as shown in Figure 1A. The optimal capillary voltage observed for all the peaks in the [Mix 3] was 3.5 to 4. kv, as shown in Figure 1B. The final MS conditions used 3.5 kv capillary voltage and 3 V cone voltage. A 6.4x1 6 1.569 Peak 1 - SQ 1: MS Scan 1: 3-1 ES+, Centroid, CV=Tune 766.5 B 4.x1 6 3.2x1 6 1.6x1 6 3.6x1 6 2.7x1 6 1.x1 6 9.x1 5 764.5 577.4 749.5 1.571 Peak 1 - SQ 1: MS Scan 1: 3-1 ES+, Centroid, CV=Tune 577.4 575.4 57.5 63.4 749.4 764.4 747.4 767.5 766.5 794.5 767.5 792.5 2 V 3 V 6.4x1 7 4.x1 7 4. kv 3.5 kv 2.5 kv 2. kv 1.5 kv 1.x1 7 7.5x1 6 5.x1 6 2.5x1 6 1.573 Peak 1 - SQ 1: MS Scan 1: 3-1 ES+, Centroid, CV=Tune 577.5 575.4 57.5 63.4 747.5 749.5 766.5 4 V 3.2x1 7 3. kv 1. kv 1.6x1 7 1.571 Peak 1 - SQ 1: MS Scan 1: 3-1 ES+, Centroid, CV=Tune 577.4 1.6x1 7 1.2x1 7 575.5.x1 6 57.5 63.5 4.x1 6 5 V 1.12 1.19 1.26 1.33 1.4 1.47 1.54 1.61 1.6 1.75 Minutes 35 42 49 56 63 7 77 4 91 9 m/z Figure 1. (A) Cone voltage screening results for L-α-phosphatidylglycerol; and (B) capillary voltage screening results for L-α-phosphatidylglycerol. 3

Chromatographic method development The sample preparation workflow was very convenient for use with the ACQUITY UPC 2 System. The chloroform/methanol diluent provided good solubility without any noticeable adverse effects on peak shape. In a typical RPLC lipid analysis, the organic extract containing the lipids would have to be evaporated and re-constituted in a more compatible solvent. When using UPC 2, however, the organic extract containing the lipids can be directly injected onto the system, thereby saving time and costs when analyzing hundreds of biological samples. Screening different column stationary phases typically changes selectivity during method development. Therefore, our initial approach was to screen three stationary phases including UPC 2 CSH Fluoro-Phenyl, UPC 2 BEH 2-EP, and UPC 2 BEH. ptimal peak shape and selectivity was achieved on the UPC 2 BEH stationary phase for the inter-class separation of the lipid mixture, as shown in Figure 2. 2.x1 2.1x1 1.4x1 7 7.x1 2.x1 1.5x1 1.x1 7 5.x1 3.2x1 2.4x1 UPC 2 CSH Fluoro-Phenyl UPC 2 BEH 2-EP UPC 2 BEH 1.6x1.x1 7 1.2 2.4 3.6 4. 6. 7.2.4 9.6 1. 12. Minutes Figure 2. Column screening of the [metdev] mixture of neutral and polar lipids. A 12-minute 1% to 5% B screening method was used. Due to less retentivity of the BEH 2-EP and CSH Fluoro-Phenyl columns, the gradients were modified (1% to 3% B) to adjust for comparative use of the separation space. The mobile phase co-solvent was 1 g/l ammonium formate in MeH derived from previously published reports. 1 Method development screening columns and modifier indicated the bridged ethylene hybrid (BEH) silica columns provided the best selectivity and peak shape. The lipid classes were identified by MS ESI+ utilizing the parameters determined by the MS optimization experiments. Injections of the individual lipid mixtures verified current peak assignments. The method used for screening the columns was optimized to focus on the inter-class separation of analytes in [Mix 3]. The previous 12-minute method was reduced and completed in 5 minutes, as shown in Figure 3. 1.6x1 PC 1.2x1 LPC.x1 7 SM CER PG PE LPE 4.x1 7.5 1. 1.5 2. 2.5 3. 3.5 4. 4.5 5. Minutes Figure 3. Injection of [Mix 3] mixture using the ACQUITY UPC 2 BEH column. The original gradient was 5% to 5% at 1.5 ml/min over 1 min with a 2 min hold at 5% B and 1-min re-equilibration at initial conditions before the next injection. The gradient was modified to 15% to 5% B at 1.5 ml/min over 3 min, held at 5% B for 2 min. The column was re-equilibrated at initial conditions before the next injection. 4

The lipid extracts purchased from Avanti provide documentation indicating various ratios of lipid intra-class constituents present within a respective standard extract. This was further confirmed when evaluating the mass spectral data for the two LPE peaks observed in chromatographic trace, as shown in Figure 4. It was found that the elution order of the molecular species within each lipid class depended on the number of double bonds on the acyl chain. Thus, the more saturated the acyl chain, the shorter the retention time. The acyl chain length has no effect on the elution order with each lipid class. Interestingly, the intra-class separation of LPE and SM standard extracts is observed when using the UPC 2 BEH stationary phase. The other stationary phases that provided broader peaks may offer a better intra-class separation of the Avanti extract standards. This hypothesis will be explored in future studies. 1.4x1 6 Combined - SQ 1: MS Scan 1: 3-1 ES+, Centroid, CV=Tune 42.3 1: m/z=42.3 H 3 C H H P H NH 2 1.5x1 6 7.x1 5 466.4 =49' 454.3 43.3 1.x1 7 3.5x1 5 54.3 1.35x1 7 43.4 467.4 4.3 Combined - SQ 1: MS Scan 1: 3-1 ES+, Centroid, CV=Tune 4.3 6 1:1 m/z=4.3 52.3 9.x1 6 4.5x1 6 1: 1:1 4.4 4.95 5.6 5.17 5.2 5.39 5.5 5.61 5.72 5.3 Minutes 4 2 341.3 464.3 42.3 52.3 H 3 C H H P H NH 2 363.1 465.4 43.5 372.2 462.2 54.2 36. 34 374. 4 442. 476. 51 544. 57. 612. m/z Figure 4. Interrogation of MS spectra for the two LPE peaks. Manipulating retentivity The method development process explored changes in gradient slope; however, changes in resolution were not significant. Experiments to manipulate retentivity were investigated. The variable which resulted in the greatest retentivity changes included the addition of a less polar solvent, such as acetonitrile, to the modifier. Two experiments were performed. The first was conducted with the original modifier composition of 1% methanol. The second experiment was conducted with modifier composition of % methanol and 2% acetonitrile. Both modifiers were doped with 1 g/l ammonium formate. In general, using acetonitrile in the modifier improved resolution, as shown in Table 1. Peak ID 1% MeH (RS) :2 MeH:ACN (RS) % Difference PG PE 2.69 3.54 +31.6 LPE 1 1.96 2.74 +39. LPE 2 1.67 2.17 +29.9 PC 1.1.56-2. SM (1) 2.24 2.7-7.6 SM (2) 1.1 1.6 +45.5 LPC 1.33 1.5 +12. Table 1. Impact of modifier composition on lipid resolution. Ceramide was excluded due to the large amount of resolution from the other peaks of interest. 5

Analysis of biological samples The methodology was used to investigate two biological samples, each for distinctly different purposes. The first example examines a mouse heart extract using the six-minute method for the rapid inter-class targeted screening of lipids with different polarity. The objective was to determine if the methodology could detect the presence of specific lipids within the hundreds of samples collected from the diabetic treatment study. This proof of concept approach will be used for further studies utilizing MS/MS quantification assessing increases of phospholipids and sphingolipids during treatment. As seen in Figure 5, many of the phospholipids and sphingolipids were easily identified in the mouse heart extract by using this targeted UPC 2 /MS method. 2.4x1 6 1.x1 6 1.2x1 6 6.x1 5 : 1: SIR Ch2 42.2 ES+, CV=Tune LPE m/z = 42.2 : 1: SIR Ch11 76.5 ES+, CV=Tune x1 7 6x1 7 4x1 7 2x1 7 PC 1.4x1 7 1.5x1 7 7.x1 6 3.5x1 6 : 1: SIR Ch3 496.3 ES+, CV=Tune LPC : 1: SIR Ch12 766.4 ES+, CV=Tune 1.2x1 7 9.x1 6 6.x1 6 3.x1 6 PG 3.2x1 6 2.4x1 6 1.6x1 6.x1 5 : 1: SIR Ch7 64.5 ES+, CV=Tune CER : 1: SIR Ch13 13.6 ES+, CV=Tune 1.x1 7 1.35x1 7 9.x1 6 4.5x1 6 SM m/z = 13.6 6 4 2 : 1: SIR Ch 72.4 ES+, CV=Tune PE : 1: SIR Ch14 15.6 ES+, CV=Tune 4x1 6 3x1 6 2x1 6 1x1 6 SM m/z = 15.5 x1 6 6x1 6 4x1 6 2x1 6 : 1: SIR Ch1 731.5 ES+, CV=Tune SM m/z = 731.5.5 1. 1.5 2. 2.5 3. 3.5 4. 4.5 Min : 1: SIR Ch1 464.2 ES+, CV=Tune 45 36 27 1 9 LPE m/z = 464.2.5 1. 1.5 2. 2.5 3. 3.5 4. 4.5 Min Figure 5. Targeted SIR analysis of a mouse heart extract. The gradient was 15% to 5% B at 1.5 ml/min over 3 min, held at 5% B for 2 min. The column was re-equilibrated at initial conditions for 1 min before the next injection. 6

Neutral lipids, such as acylglyceride and cholesterol esters, are characteristically non-polar. Typically, plant metabolomic profiling distinguishes heterogeneous distribution of neutral lipids, such as triacylglycerols and diacylgylcerols 2 at different conditions. The example in Figure 6 investigates lipids present in a cotton seed oil extract. The data was collected using MS E on a SYNAPT G2 Mass Spectrometer allowing for the characterization of the neutral lipids by precursor and product ion alignment. During the method development process, many neutral lipids eluted near the chromatographic void when starting the compositional gradient above 5% modifier using methanol (or methanol/acetonitrile). In this example, the UPC 2 /MS method was modified to retain the neutral lipids by reducing the starting percentage of modifier. The modifier was ramped to elute the polar lipids, known to be present as membrane lipid classes in cotton embryos. 2 By using this approach, the chromatography can be altered to provide greater retention, and often greater specificity for the neutral lipids. From an analytical technique perspective, the elution mechanisms are conceptually similar to performing a mobile phase gradient elution profile by liquid chromatography. TAG Low energy DAG PC 5% NAPE High energy 2% Figure 6. Comprehensive profiling of a cotton seed oil extract. The gradient was 2% to 5% B over 5 min, increased to 5% B over 1 min, and held at 5% B for 2 min using a flow rate of 1.5 ml/min. The column was re-equilibrated at initial conditions for 1 min before the next injection. 7

C N C LUSINS A flexible universal method was developed for the analysis of inter-class separations of neutral and amphipathetic lipids. Since the goal of the experiment was to achieve flexible parameters providing the separation of lipids by class, the core methodology using the ACQUITY UPC 2 BEH column, methanol/acetonitrile modifier with ammonium formate as an additive provided the best results. The gradient methodology and run time was adjustable to focus on rapid screening or comprehensive profiling of lipids in biological samples. The lipid sample preparation workflow is suitable for UPC 2. The organic phase of the biological lipid extract can be directly injected onto the ACQUITY UPC 2 System with MS detection, thereby saving time and operating costs. The rapid inter-class screening provided an analysis within seven minutes including re-equilibration. The MS spectral information confirmed instances of intra-class separation by distinguishing between the degrees of saturation, as demonstrated for the Lyso- Phosphatidylethanolamine separation on the ACQUITY UPC 2 BEH column. Resolution can be increased within the chromatographic space by the addition of acetonitrile. For this methodology, an increase of 3% to 4% resolution can be observed between lipid classes for the majority of the analytes. The method development knowledge gained from these experiments build a foundation for the applicability of lipid analysis by convergence chromatography. References 1. Bamba T, Shimonishi N, et al. High throughput and exhaustive analysis of diverse lipids by using supercritical fluid chromatography-mass spectrometry for metabolomics. J Biosci Bioengin. 2 May; 15(5): 46-469. 2. Horn PJ, Korte AR, Neogi PB, et al. Spatial Mapping of Lipids at Cellular Resolution in Embryos of Cotton. Plant Cell. 212 Feb; 24(2): 622-636. Waters, ACQUITY, SYNAPT, Empower, and MassLynx are registered trademarks of Waters Corporation. UltraPerformance Convergence Chromatography, UPC 2, ACQUITY UPC 2, and The Science of What s Possible are trademarks of Waters Corporation. All other trademarks are the property of their respective owners. 213 Waters Corporation. Produced in the U.S.A. February 213 724579EN AG-PDF Waters Corporation 34 Maple Street Milford, MA 1757 U.S.A. T: 1 5 47 2 F: 1 5 72 199 www.waters.com